$MJNA Dr. Titus continues: "Every country operates under different laws and regulations. In Brazil, although not a clinically tested medication that has been approved for this purpose, patients and their doctors may access any product around the globe that may show benefit for that patient's condition. So far, our products have fallen into this category within Brazil with now four potential indications for doctors to write prescriptions.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.